documented. This study descriptively compares these aspects among CU patients residing
in Europe (EU) and Central and South America (C/SA). Methods AWARE (A World-wide
Antihistamine-Refractory chronic urticaria patient Evaluation) is a global prospective, non-
interventional study of CU in the real-world setting. Patients were≥ 18 years with a
diagnosis of H1-antihistamine-refractory CU for> 2 months. Differences between the EU and …